Game-Based Education and Treatment Adherence in Type 2 Diabetes
The Effect of Game-based Education on Adherence to Treatment and Anxiety Level in Type 2 Diabetics Started on Insulin Therapy
1 other identifier
interventional
72
1 country
1
Brief Summary
The goal of this clinical trial is to learn if an education program can help lower anxiety and improve treatment follow-up in adults with type 2 diabetes. The main questions it aims to answer are: Does attending the education program lower anxiety levels? Does it help people better follow their diabetes treatment plan? Researchers will compare two groups: Education group: Participants who attend the program. Control group: Participants who do not attend the program. Participants will: Be randomly assigned to either the education group or the control group. Attend four weekly sessions, each lasting two hours, over one month (education group only). Complete surveys before and after the program, including the Beck Anxiety Scale (to measure anxiety) and the Patient Compliance Scale for Type 2 Diabetes Mellitus Treatment (to measure treatment follow-up).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable type-2-diabetes
Started Apr 2024
Shorter than P25 for not_applicable type-2-diabetes
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 5, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 3, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2024
CompletedFirst Submitted
Initial submission to the registry
September 11, 2025
CompletedFirst Posted
Study publicly available on registry
September 26, 2025
CompletedSeptember 26, 2025
September 1, 2025
28 days
September 11, 2025
September 25, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Treatment Compliance Levels
For Treatment Compliance: The level of compliance among individuals undergoing diabetes-to-diabetes treatment was determined using the Patient Compliance Scale for Type 2 Diabetes Treatment, a 30-item, five-point Likert-type scale. A low total score indicates high patient compliance. For Anxiety: "Anxiety levels of individuals with diabetes were determined using the Beck Anxiety Scale (BAS), a 21-item, four-point Likert-type self-report scale. Higher scores indicate more severe anxiety.
Pre-intervention and Post-intervention (After 1 Month of Training)
Study Arms (2)
Game-Based Education
EXPERIMENTALArm Description: Participants in this group will receive diabetes education using the "Let's Learn Diabetes" board game. The program consists of four weekly sessions, each lasting two hours, conducted over one month. The sessions aim to improve diabetes knowledge, reduce anxiety, and increase adherence to insulin therapy.
Traditional Diabetes Education
ACTIVE COMPARATORParticipants in the control group will receive standard diabetes education through traditional lecture-based presentations. The education schedule matches the experimental group with four weekly sessions, each lasting two hours, over one month.
Interventions
Participants in the experimental group will receive diabetes education using the "Let's Learn Diabetes" board game. The program consists of four weekly sessions, each lasting two hours, over one month. The intervention is designed to improve diabetes knowledge, reduce anxiety, and enhance treatment adherence among patients with Type 2 Diabetes Mellitus on insulin therapy.
Participants in the control group will receive standard diabetes education through traditional lecture-based presentations. The education schedule matches the experimental group with four weekly sessions, each lasting two hours, over one month.
Eligibility Criteria
You may not qualify if:
- Age at diagnosis of diabetes is recent or less than 1 year.
- Being on insulin therapy for more than three months.
- Mental or psychological comorbidity.
- Not within the target age range, under 40 years or over 65 years.
- Refusing to participate in the research.
- Not attending one or more of the four training sessions during the research process.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Izmir Tinaztepe Universitylead
- Usak State Hospitalcollaborator
Study Sites (1)
Uşak Eğitim Ve Araştırma Hastanesi
Uşak, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Gönül düzgün, phd
Izmir Tinaztepe University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- assistant profesor
Study Record Dates
First Submitted
September 11, 2025
First Posted
September 26, 2025
Study Start
April 5, 2024
Primary Completion
May 3, 2024
Study Completion
November 30, 2024
Last Updated
September 26, 2025
Record last verified: 2025-09